This protracted plateauing we're experiencing to me is quite common for biotech stocks...I've seen it numerous times and it's why I am still very confident.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025